MLICM
Metropolitan Life Insurance Company (MetLife) Portfolio holdings
AUM
$335M
1-Year Return
7.01%
This Quarter Return
+0.24%
1 Year Return
+7.01%
3 Year Return
+65.15%
5 Year Return
+135.64%
10 Year Return
+335.37%
AUM
$14.2B
AUM Growth
+$627M
(+4.6%)
Cap. Flow
+$731M
Cap. Flow
% of AUM
5.14%
Top 10 Holdings %
Top 10 Hldgs %
13.81%
Holding
2,756
New
535
Increased
582
Reduced
1,557
Closed
56
Top Buys
| 1 |
AT&T
T
|
+$103M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$91.2M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$54.1M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$25.1M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$22.9M |
Top Sells
| 1 |
iShares National Muni Bond ETF
MUB
|
+$25.9M |
| 2 |
LO
LORILLARD INC COM STK
LO
|
+$13.8M |
| 3 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$10.1M |
| 4 |
Edgewell Personal Care
EPC
|
+$7.56M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$4.67M |
Sector Composition
| 1 | Financials | 13.32% |
| 2 | Technology | 13.06% |
| 3 | Healthcare | 12.81% |
| 4 | Industrials | 9.97% |
| 5 | Energy | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Azenta
AZTA
$1.36B
| $512K | ﹤0.01% |
44,742
-11,343
| -20% | -$130K |
|
1727
Inogen
INGN
$231M
| $512K | ﹤0.01% |
+11,471
| New | +$512K |
|
|
VMW
1728
DELISTED
VMware, Inc
VMW
| $512K | ﹤0.01% |
5,977
-198
| -3% | -$17K |
|
1729
Norwegian Cruise Line
NCLH
$12B
| $511K | ﹤0.01% |
9,118
+3,000
| +49% | +$168K |
|
1730
Enanta Pharmaceuticals
ENTA
$177M
| $510K | ﹤0.01% |
11,325
+3,103
| +38% | +$140K |
|
|
EPZM
1731
DELISTED
Epizyme, Inc
EPZM
| $510K | ﹤0.01% |
21,241
+10,959
| +107% | +$263K |
|
1732
CTS Corp
CTS
$1.23B
| $509K | ﹤0.01% |
26,392
-1,405
| -5% | -$27.1K |
|
|
MCRL
1733
DELISTED
MICREL INC
MCRL
| $509K | ﹤0.01% |
36,591
-3,429
| -9% | -$47.7K |
|
|
RKUS
1734
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $508K | ﹤0.01% |
49,164
-1,556
| -3% | -$16.1K |
|
1735
Acco Brands
ACCO
$361M
| $506K | ﹤0.01% |
65,110
-23,841
| -27% | -$185K |
|
|
EGRX
1736
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $506K | ﹤0.01% |
+6,254
| New | +$506K |
|
|
VASC
1737
DELISTED
Vascular Solutions Inc
VASC
| $506K | ﹤0.01% |
+14,574
| New | +$506K |
|
1738
Omeros
OMER
$282M
| $505K | ﹤0.01% |
28,078
-1,266
| -4% | -$22.8K |
|
|
FRED
1739
DELISTED
Fred's Inc
FRED
| $505K | ﹤0.01% |
+26,193
| New | +$505K |
|
1740
Cavco Industries
CVCO
$4.32B
| $504K | ﹤0.01% |
6,677
-295
| -4% | -$22.3K |
|
|
1741
Ionis Pharmaceuticals
IONS
$10.1B
| $503K | ﹤0.01% |
8,733
-81,088
| -90% | -$4.67M |
|
|
NGHC
1742
DELISTED
National General Holdings Corp
NGHC
| $503K | ﹤0.01% |
24,126
-840
| -3% | -$17.5K |
|
|
XLRN
1743
DELISTED
Acceleron Pharma Inc.
XLRN
| $501K | ﹤0.01% |
15,844
+2,859
| +22% | +$90.4K |
|
1744
Walker & Dunlop
WD
$2.93B
| $500K | ﹤0.01% |
18,704
+4,821
| +35% | +$129K |
|
|
PRFT
1745
DELISTED
Perficient Inc
PRFT
| $499K | ﹤0.01% |
25,912
-1,432
| -5% | -$27.6K |
|
1746
Flotek Industries
FTK
$341M
| $498K | ﹤0.01% |
6,623
-284
| -4% | -$21.4K |
|
1747
National Healthcare
NHC
$1.78B
| $498K | ﹤0.01% |
7,665
-349
| -4% | -$22.7K |
|
1748
W.P. Carey
WPC
$15B
| $497K | ﹤0.01% |
8,612
-7,781
| -47% | -$449K |
|
1749
Tempest Therapeutics
TPST
$45.5M
| $495K | ﹤0.01% |
6
+1
| +20% | +$82.5K |
|
1750
US Physical Therapy
USPH
$1.22B
| $495K | ﹤0.01% |
9,038
-548
| -6% | -$30K |
|